OOIR: Observatory of International Research

Papers

(The TQCC of Cancer Science is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
TIFA promotes colorectal cancer cell proliferation in an RSK‐ and PRAS40‐dependent manner	541
Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders	140
Issue Information	102
Issue Information	100
Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial	86
Issue Information	82
Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center	79
Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors	77
Novel and efficient method for culturing patient‐derived gastric cancer stem cells	76
LINC01605 promotes aerobic glycolysis through lactate dehydrogenase A in triple‐negative breast cancer	71
Efficacy and biomarker analysis of second‐line nab‐paclitaxel plus sintilimab in patients with advanced biliary tract cancer	69
Issue Information	68
A Multicenter Phase II Trial of Nimustine Hydrochloride Administered via Convection‐Enhanced Delivery in Children With DIPG	67
Expression of Concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK and endothelial nitric oxide syn	65
Correction to “Expression of concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK	64
Identification of sequence polymorphism in the D‐loop region of mitochondrial DNA as a risk factor for breast cancer	63
Correction to “ELF3‐AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood”	60
Novel CHI3L1‐Associated Angiogenic Phenotypes Define Glioma Microenvironments: Insights From Multi‐Omics Integration	58
GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A	57
Thrombospondin‐1 induced programmed death‐ligand 1‐mediated immunosuppression by activating the STAT3 pathway in osteosarcoma	53
Tumor exosomal RNPEP promotes lung metastasis of liver cancer via inducing cancer‐associated fibroblast activation	53
PHAX enhanced LIN28B‐mediated PBX3 mRNA stability to promote esophageal cancer development	52
Issue Information	51
Chemokine C‐C motif ligand 21 synergized with programmed death‐ligand 1 blockade restrains tumor growth	51
Interleukin‐4 induced 1‐mediated resistance to an immune checkpoint inhibitor through suppression of CD8⁺ T cell infiltration in melanoma	50

EGFR inhibition in EGFR‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment	50
Trends in incidence and overdiagnosis of thyroid cancer in China, Japan, and South Korea	49
Retraction	49
Dysregulated minor intron splicing in cancer	46
Methyltransferase‐like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6‐methyladenosine‐dependent manner	45
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine	45
Genome‐wide loss‐of‐function genetic screen identifies INSIG2 as the vulnerability of hepatitis B virus‐integrated hepatoma cells	44
LHPP‐P38 MAPK/ERK‐ETS1 Axis Negative Feedback Signaling Restrains Progression in Breast Cancer	42
Susceptibility of Brca1^(L63X/+) rat to ovarian reserve dissipation by chemotherapeutic agents to breast cancer	41
Comparison of ¹¹C‐Acetate and ¹⁸F‐FDG PET/CT for Immune Infiltration and Prognosis in Hepatocellular Carcinoma	41
Real‐World Data Analysis of Genomic Alterations Detected by a Dual DNA–RNA Comprehensive Genomic Profiling Test	41
TGF‐β signaling promotes desmoid tumor formation via CSRP2 upregulation	40
Feedforward loop between IMP1 and YAP/TAZ promotes tumorigenesis and malignant progression in glioblastoma	40
Formin‐like 2 promotes angiogenesis and metastasis of colorectal cancer by regulating the EGFL6/CKAP4/ERK axis	40
Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9	39
	38
Tumor‐associated macrophage‐derived transforming growth factor‐β promotes colorectal cancer progression through HIF1‐TRIB3 signaling	38
Epidemiology of skin cancer based on Japan's National Cancer Registry 2016–2017	38
Induction of immunogenic cell death in murine colon cancer cells by ferrocene‐containing redox phospholipid polymers	37
The emerging multifaceted role of PINK1 in cancer biology	37
Limb expression 1‐like protein promotes epithelial–mesenchymal transition and epidermal growth factor receptor‐tyrosine kinase inhibitor resistance via nucleolin‐mediated ribosomal RNA synt	37
PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway	36
Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes	36
A Contrast‐Enhanced Ultrasound Cine‐Based Deep Learning Model for Predicting the Response of Advanced Hepatocellular Carcinoma to Hepatic Arterial Infusion Chemotherapy Combined With Systemic Therapie	36
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell‐specific liposomal siRNA delivery system	36
In This Issue	35
In This Issue	35
In this issue	35
C644‐0303, a small‐molecule inhibitor of the Wnt/β‐catenin pathway, suppresses colorectal cancer growth	34
Biological effectiveness and relative biological effectiveness of ion beams for in‐vitro cell irradiation	34
Lysyl oxidase‐like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3	34
MUSASHI‐2 confers resistance to third‐generation EGFR‐tyrosine kinase inhibitor osimertinib in lung adenocarcinoma	34
Personalized medicine with germline pathogenic variants: Importance of population‐ and region‐wide evidence	34
A gain‐of‐function mutation in microRNA 142 is sufficient to cause the development of T‐cell leukemia in mice	34
Retinol binding protein 1‐dependent activation of NF‐ κB signaling enhances the malignancy of non‐glioblastomatous diffuse gliomas	34
AKT3 is a key regulator of head and neck squamous cell carcinoma	33
Issue Information	33
Effect of fasting on cancer: A narrative review of scientific evidence	33
Hepatic stellate cell‐released CXCL1 aggravates HCC malignant behaviors through the MIR4435‐2HG/miR‐506‐3p/TGFB1 axis	32
Pleckstrin‐2‐promoted PPM1B degradation plays an important role in transforming growth factor‐β‐induced breast cancer cell invasion and metastasis	31
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis	31
Chronological improvement in precision oncology implementation in Japan	31
Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816	31
Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long‐term outcomes from a phase I trial	31
Exosome‐delivered miR‐221/222 exacerbates tumor liver metastasis by targeting SPINT1 in colorectal cancer	31
Multiplex plasma protein assays as a diagnostic tool for lung cancer	31
Genotype–phenotype correlation for extracolonic aggressive phenotypes in patients with familial adenomatous polyposis	31
The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma	30
Serial comprehensive genomic profiling by next‐generation sequencing for patients with metastatic colorectal cancer	30
Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif‐containing 37‐induced tumor necrosis factor receptor‐associated factor 2 ubiquitination	30

Correction	29
Recurrent PTPRZ1‐MET fusion and a high occurrence rate of MET exon 14 skipping in brain metastases	29
ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy	29
Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity	29
In This Issue	29
Prognostic impact of the presence or absence of prior cancer in patients with cancer using cure models: A population‐based study	29
Promotion of squamous cell carcinoma tumorigenesis by oncogene‐mediated THG‐1/TSC22D4 phosphorylation	29
Correction to “G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptor”	28
When and how should next‐generation sequencing and comprehensive genomic profiling assays be performed?	28
HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer	28
Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK‐dependent colorectal cancer	28
	28
Rafoxanide negatively modulates STAT3 and NF‐κB activity and inflammation‐associated colon tumorigenesis	28
Concerning trends and potential issues in osteosarcoma research publication	28
Survival rate prediction of nasopharyngeal carcinoma patients based on MRI and gene expression using a deep neural network	28
Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer	27
LRRC75A‐AS1 delivered by M2 macrophage exosomes promotes cervical cancer progression via enhancing SIX1 expression	27
CDX2 Promoter‐Controlled Oncolytic Adenovirus Suppresses Tumor Growth and Liver Metastasis of Colorectal Cancer	27
Selective autophagy	27
Evaluating the effect of childhood sunburn on the risk of cutaneous melanoma through Mendelian randomization	26
FZD10‐targeted α‐radioimmunotherapy with ²²⁵Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model	26
Correction	26
ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP‐2 signaling	26
LS‐106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo	26
In this issue	26
Gut microbiome as a biomarker for predicting early recurrence of HBV‐related hepatocellular carcinoma	26
IL‐27 improves adoptive CD8⁺ T cells’ antitumor activity via enhancing cell survival and memory T cell differentiation	26
	25
BBOX1‐AS1 promotes gastric cardia adenocarcinoma progression via interaction with CtBP2 to facilitate the epithelial–mesenchymal transition process	25
H1.0 induces paclitaxel‐resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor	25
Growth pattern of de novo small clusters of colorectal cancer is regulated by Notch signaling at detachment	25
RNA‐binding protein SAMD4A inhibits breast tumor angiogenesis by modulating the balance of angiogenesis program	25
Cholesterol synthesis is essential for the growth of liver metastasis‐prone colorectal cancer cells	25
Novel specific anti‐ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis	24
C/EBPβ induces B‐cell acute lymphoblastic leukemia and cooperates with BLNK mutations	24
Circulating cancer‐associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer	24
Transferrin Receptor Promotes Endometrial Cancer Proliferation by Activating the Iron‐Dependent PI3K/AKT/mTOR Signaling Pathway	24
Long noncoding RNA plasmacytoma variant translocation 1 promotes progression of colorectal cancer by sponging microRNA‐152‐3p and regulating E2F3/MAPK8 signaling	24
Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population‐based cohort studies in Japan	24
Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics	24
CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR‐33a/b to disinhibit PD‐L1	24
CD44v5 domain regulates crosstalk between TNBC cells and tumor‐associated macrophages by enhancing the IL‐4R/STAT3 axis	24
HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer	24
Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer	23
Rev1 overexpression accelerates N‐methyl‐N‐nitrosourea (MNU)‐induced thymic lymphoma by increasing mutagenesis	23
Fibrocytes in tumor microenvironment: Identification of their fraction and novel therapeutic strategy	23
Silybin suppresses ovarian cancer cell proliferation by inhibiting isocitrate dehydrogenase 1 activity	23
	23
Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma	23
Impact of Minimal Residual Disease on Early Recurrence of Liver Metastatic Colorectal Cancer	23
Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi‐institutional study	23
Clinical outcomes and prognostic factors following the surgical resection of renal cell carcinoma spinal metastases	23
Intraperitoneal transfer of microRNA‐29b‐containing small extracellular vesicles can suppress peritoneal metastases of gastric cancer	23
RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJ	23
Phase I trial of apatinib and paclitaxel+oxaliplatin+5‐FU/levoleucovorin for treatment‐naïve advanced gastric cancer	23
Antibody‐drug conjugate MORAb‐202 exhibits long‐lasting antitumor efficacy in TNBC PDx models	22
Molecular subtyping of small‐cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies	22
Carbon‐ion radiotherapy for oligometastatic liver disease: A national multicentric study by the Japan Carbon‐Ion Radiation Oncology Study Group (J‐CROS)	22
Methyltransferase like‐14 suppresses growth and metastasis of non‐small‐cell lung cancer by decreasing LINC02747	22
Upregulation of Nogo‐B by hypoxia inducible factor‐1 and activator protein‐1 in hepatocellular carcinoma	22
Correction to Circular RNA hsa_circ_001895 serves as a sponge of microRNA‐296‐5p to promote clear cell renal cell carcinoma progression by regulating SOX12	22
Association between adherence to Eat‐Lancet diet and incidence and mortality of lung cancer: A prospective cohort study	22
M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potent	22
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK‐rearranged non‐small cell lung cancer	22
Neon ion (²⁰Ne¹⁰⁺) charged particle beams manipulate rapid tumor reoxygenation in syngeneic mouse models	22
Attitudes toward cancer screening in regional Japan during the COVID‐19 pandemic: An anonymous survey	21
In this Issue	21
	21
Incidence of second primary cancers among survivors of childhood cancer: A population‐based study, Osaka, Japan, 1975–2015	21
PD‐1 blockade treatment in melanoma: Mechanism of response and tumor‐intrinsic resistance	21
ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN‐Amplified Neuroblastoma	21
Metabolism score and machine learning models for the prediction of esophageal squamous cell carcinoma progression	21
GADD45β‐MTK1 signaling axis mediates oncogenic stress‐induced activation of the p38 and JNK pathways	21
Abstracts	21
	21
Fibrous corona is reduced in cancer cell lines that attenuate microtubule nucleation from kinetochores	21
In this issue	21
Glycoprotein NMB promotes tumor formation and malignant progression of laryngeal squamous cell carcinoma	21
Dysfunction of CD8⁺ T cells around tumor cells leads to occult lymph node metastasis in NSCLC patients	21
Immunoglobulin‐like transcript 2 blockade restores antitumor immune responses in glioblastoma	21

Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non–small‐cell lung cancer (NEJ056)	21
High PTX3 expression is associated with a poor prognosis in diffuse large B‐cell lymphoma	20
Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast	20
Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer‐VTE Registry)	20
In this issue	20
Multiple cancer type classification by small RNA expression profiles with plasma samples from multiple facilities	20
Pan‐immune‐inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer	20
Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L	20
ELF1 suppresses autophagy to reduce cisplatin resistance via the miR‐152‐3p/NCAM1/ERK axis in lung cancer cells	20
Role of catecholamine synthases in the maintenance of cancer stem‐like cells in malignant peripheral nerve sheath tumors	20
A nationwide birth year‐by‐year analysis of effectiveness of HPV vaccine in Japan	20
Fat mass and obesity‐associated protein regulates arecoline‐exposed oral cancer immune response through programmed cell death‐ligand 1	20
Prediction of the effects of radiation therapy in esophageal cancer using diffusion and perfusion MRI	20
Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome	20
Novel LAMC2 fusion protein has tumor‐promoting properties in ovarian carcinoma	20
Mutation Analysis of TMB‐High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications	20
Three‐year survival from diagnosis in surgically treated patients in designated and nondesignated cancer care hospitals in Japan	20
SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1	20
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments	20
An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth	19
MED27 plays a tumor‐promoting role in breast cancer progression by targeting KLF4	19
The ALK inhibitors, alectinib and ceritinib, induce ALK‐independent and STAT3‐dependent glioblastoma cell death	19
Issue Information	19
Adaptive use of error‐prone DNA polymerases provides flexibility in genome replication during tumorigenesis	19
Serum untargeted metabolomics reveal metabolic alteration of non‐small cell lung cancer and refine disease detection	19
MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma	19
A single immunization with cellular vaccine confers dual protection against SARS‐CoV‐2 and cancer	19
Intratumor heterogeneity of lymphoma identified by multiregion sequencing of autopsy samples	19
Activated macrophages promote invasion by early colorectal cancer via an interleukin 1β‐serum amyloid A1 axis	19
Senescence and senolysis in cancer: The latest findings	19
Spatial omics technologies for understanding molecular status associated with cancer progression	19
Phospholipid metabolic adaptation promotes survival of IDH2 mutant acute myeloid leukemia cells	19
Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR‐671‐5p/LGALS3BP/NF‐κB axis	18
Elotuzumab‐mediated ADCC with Th1‐like Vγ9Vδ2 T cells to disrupt myeloma–osteoclast interaction	18
Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma	18
CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma	18
Single‐cell transcriptomic analysis of gingivo‐buccal oral cancer reveals two dominant cellular programs	18
SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2	18
Changes in survival of patients with non–small cell lung cancer in Japan: An interrupted time series study	18
Tertiary lymphoid structure and neutrophil–lymphocyte ratio coordinately predict outcome of pembrolizumab	18
Characterization of the large‐scale Japanese patient‐derived xenograft (J‐PDX) library	18
Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice	18
Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene	18
Transcriptional suppression of Dicer by HOXB‐AS3/EZH2 complex dictates sorafenib resistance and cancer stemness	18
Characterization and clinical implications of different malignant transformation patterns in diffuse low‐grade gliomas	18
Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia	18
A combination of lymphatic drug delivery of anti‐CTLA‐4 antibody and local radiotherapy for solid‐tumor treatment	18
Multiple‐level copy number variations in cell‐free DNA for prognostic prediction of HCC with radical treatments	18
First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*	18
SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling	17
Evans Blue Acts as a Selective Inhibitor of CaMKII‐α to Impede the Progression of TCL Identified by HTS	17
Metabolic stress‐induced reciprocal loop of long noncoding RNA ZFAS1 and ZEB1 promotes epithelial–mesenchymal transition and metastasis of pancreatic cancer cells	17
STAT3 regulates 5‐Fu resistance in human colorectal cancer cells by promoting Mcl‐1–dependent cytoprotective autophagy	17
Senescent CD8⁺ T cells acquire NK cell‐like innate functions to promote antitumor immunity	17
Cross‐talk between gastric cancer and hepatic stellate cells promotes invadopodia formation during liver metastasis	17
Mannose and phosphomannose isomerase regulate energy metabolism under glucose starvation in leukemia	17
Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non‐small‐cell lung cancer patients	17
Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance	17
Second Opinion Referrals of Cancer Patients in Japan—A Nationwide Study	17
Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation‐dependent probe amplification	17
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia	17
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort	17
ZNF500 abolishes breast cancer proliferation and sensitizes chemotherapy by stabilizing P53 via competing with MDM2	17
Growth arrest‐specific transcript 5 represses endometrial cancer development by promoting antitumor function of tumor‐associated macrophages	17
Alvocidib inhibits IRF4 expression via super‐enhancer suppression and adult T‐cell leukemia/lymphoma cell growth	16
The cancer epigenome: Non‐cell autonomous player in tumor immunity	16
Metronomic chemotherapy for indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract	16
p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case‐cohorts within a Japanese prospective study	16
RETRACTION: MicroRNA‐16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor‐κB1/MMP9 signaling pathway	16
Dhx15 regulates zebrafish definitive hematopoiesis through the unfolded protein response pathway	16
Methyltransferase‐like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1	16
CORRECTION	16
Long‐term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old	16
Cancer metabolism challenges genomic instability and clonal evolution as therapeutic targets	16
Trends in patterns of treatment and survival of colorectal cancer patients using cancer registry data in Japan: 1995–2015	16
In this issue	16
CircBRD7 attenuates tumor growth and metastasis in nasopharyngeal carcinoma via epigenetic activation of its host gene	16
Correction	16
CORRECTION	16
Fat and proteolysis due to methionine, tryptophan, and niacin deficiency leads to alterations in gut microbiota and immune modulation in inflammatory bowel disease	16
New insights into the genetic contribution of ALDH2 rs671 in pancreatic carcinogenesis: Evaluation by mediation analysis	16
Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer	15
MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer	15
hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2/M1 macrophages through the miR‐139‐3p/CCL5 axis	15
Role of EMT in the DNA damage response, double‐strand break repair pathway choice and its implications in cancer treatment	15
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine	15
circEZH2^E2^/E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression	15
AXL‐Mediated Drug Resistance in ALK‐Rearranged NSCLC Enhanced by GAS6 From Macrophages and MMP11 Positive Fibroblasts	15
Intercellular adhesion molecule‐1‐targeted near‐infrared photoimmunotherapy of triple‐negative breast cancer	15
Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer: ¹⁸F‐labeled rBC2LCN lectin	15
KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation	15
Cancer cell‐derived exosomal miR‐20a‐5p inhibits CD8⁺ T‐cell function and confers anti‐programmed cell death 1 therapy resistance in triple‐negative breast	15
Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma	15
Patient survey on cancer genomic medicine in Japan under the national health insurance system	15
Deubiquitinase ubiquitin‐specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augment immune escape and metastasis of pancrea	15